Amortization of Intangible Assets in USD of Predictive Oncology Inc. from Q2 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Predictive Oncology Inc. quarterly/annual Amortization of Intangible Assets history and change rate from Q2 2013 to Q3 2025.
  • Predictive Oncology Inc. Amortization of Intangible Assets for the quarter ending 30 Sep 2025 was $1.14K, a 8.19% decline year-over-year.
  • Predictive Oncology Inc. Amortization of Intangible Assets for the twelve months ending 30 Sep 2025 was $4.68K.
  • Predictive Oncology Inc. annual Amortization of Intangible Assets for 2024 was $4.98K, a 0.5% increase from 2023.
  • Predictive Oncology Inc. annual Amortization of Intangible Assets for 2023 was $4.96K, a 98.8% decline from 2022.
  • Predictive Oncology Inc. annual Amortization of Intangible Assets for 2022 was $415K, a 10.8% increase from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Change (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Change (%)

Predictive Oncology Inc. Quarterly Amortization of Intangible Assets (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $4.68K $1.14K -$102 -8.19% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $4.78K $1.14K -$102 -8.19% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 $4.88K $1.14K -$102 -8.19% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $4.98K $1.25K +$16.6K 01 Oct 2024 31 Dec 2024 8-K 18 Jul 2025
Q3 2024 -$11.6K $1.25K -$5.38K -81.2% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 -$6.25K $1.25K -$5.79K -82.3% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 -$461 $1.25K -$5.42K -81.3% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $4.96K -$15.4K -$119K -115% 01 Oct 2023 31 Dec 2023 8-K 18 Jul 2025
Q3 2023 $124K $6.62K -$97.2K -93.6% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $222K $7.04K -$96.3K -93.2% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 $318K $6.67K -$96.9K -93.6% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 $415K $104K -$20.6K -16.5% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $435K $104K +$20.2K +24.1% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 $415K $103K +$20.3K +24.4% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 $395K $104K +$20.5K +24.7% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $374K $125K +$41.8K +50.5% 01 Oct 2021 31 Dec 2021 10-K 21 Mar 2023
Q3 2021 $333K $83.6K +$6.36K +8.23% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $326K $83.1K +$5.9K +7.65% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $320K $83K +$6.54K +8.55% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $314K $82.8K -$8.31K -9.12% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $322K $77.3K -$16.2K -17.3% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $338K $77.2K -$11.2K -12.7% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021
Q1 2020 $349K $76.5K +$58.9K +334% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021
Q4 2019 $291K $91.1K +$74.6K +452% 01 Oct 2019 31 Dec 2019 10-K 15 Mar 2021
Q3 2019 $216K $93.4K +$55K +143% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 $161K $88.4K +$84.3K +2072% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020
Q1 2019 $76.6K $17.6K +$14K +381% 01 Jan 2019 31 Mar 2019 10-Q 08 Jun 2020
Q4 2018 $62.6K $16.5K +$12.9K +356% 01 Oct 2018 31 Dec 2018 10-K 01 Apr 2020
Q3 2018 $49.8K $38.4K +$35.1K +1072% 01 Jul 2018 30 Sep 2018 10-Q 15 Nov 2019
Q2 2018 $14.6K $4.07K +$1.17K +40.2% 01 Apr 2018 30 Jun 2018 10-Q 19 Aug 2019
Q1 2018 $13.5K $3.67K +$783 +27.1% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 $12.7K $3.62K +$741 +25.7% 01 Oct 2017 31 Dec 2017 10-K/A 02 Apr 2019
Q3 2017 $11.9K $3.28K +$761 +30.3% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 $11.2K $2.9K +$1.02K +54.5% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 $10.2K $2.89K +$1.06K +57.6% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 $9.11K $2.88K +$1.11K +62.7% 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2018
Q3 2016 $8K $2.52K +$883 +54.1% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 $7.11K $1.88K +$434 +30.1% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 $6.68K $1.83K +$388 +26.9% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 $6.29K $1.77K 01 Oct 2015 31 Dec 2015 10-K 15 Mar 2017
Q3 2015 $1.63K +$1.63K 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 $1.44K +$1.44K 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2016
Q1 2015 $1.44K +$1.44K 01 Jan 2015 31 Mar 2015 10-Q 23 May 2016
Q3 2014 $0 01 Jul 2014 30 Sep 2014 10-Q 09 Dec 2015
Q2 2014 $0 -$141K -100% 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015
Q1 2014 $0 01 Jan 2014 31 Mar 2014 10-Q 18 May 2015
Q2 2013 $141K 14 Jun 2013 30 Jun 2013 10-K 30 Apr 2015

Predictive Oncology Inc. Annual Amortization of Intangible Assets (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.98K +$25.00 +0.5% 01 Jan 2024 31 Dec 2024 8-K 18 Jul 2025
2023 $4.96K -$410K -98.8% 01 Jan 2023 31 Dec 2023 8-K 18 Jul 2025
2022 $415K +$40.4K +10.8% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 $374K +$60.6K +19.3% 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2023
2020 $314K +$23.2K +7.97% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 $291K +$228K +364% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2021
2018 $62.6K +$49.9K +394% 01 Jan 2018 31 Dec 2018 10-K 01 Apr 2020
2017 $12.7K +$3.58K +39.3% 01 Jan 2017 31 Dec 2017 10-K/A 02 Apr 2019
2016 $9.11K +$2.82K +44.8% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018
2015 $6.29K 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2017
2013 $141K 01 Jan 2013 31 Dec 2013 10-Q 12 Nov 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.